fig3
![The narrow ridge from liver damage to hepatocarcinogenesis](https://image.oaes.cc/a77fec08-366d-4cc6-98a4-1e83bd4125ca/3998.fig.3.jpg)
Figure 3. Systemic treatment algorithm proposed by the authors. Therapeutical regimens should be selected in adaption to patients’ comorbidities, liver function, tumor burden/localization, AFP level, and tolerance to previous systemic treatment. AFP: Alpha-fetoprotein.